Introduction: Diabetic polyneuropathy with loss of protective sensitivity of the peripheral system is a major risk factor for one or more ulcerations followed by amputation of the foot. Semmes-Weinstein monofilament is used to diagnose this potential complication of diabetes in many specialized centers.
Aim: The aim of this article is to introduce a scientifically proven, effective, and affordable tool for preventive examination of patients with diabetes in the general medical practice.
Materials and Methods: Review of medical literature from recent years has been conducted.
Results: Semmes-Weinstein monofilament testing is a good and easily applicable method for painless and effective screening of diabetic neuropathy, with positive evidence-based prognostic characteristics. An additional advantage is that the monofilament is easily portable and convenient for use by general practitioners.
Conclusion: Testing for impaired sensitivity to Semmes-Weinstein monofilament is a safe, effective and inexpensive method for seeking patients with diabetic neuropathy in the General practitioner’s office and would reduce the risk of developing diabetic foot.
Albers JW, Pop-Busui R. Diabetic neuropathy: mechanisms, emerging treatments, and subtypes. Curr Neurol Neurosci Rep 2014;14:473
Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med 1998; 158: 289–292.
Bild DE, Selby JV , Sinnock P , Brower WS, Braverman P , Showstack JA. Lower extremity amputation in people with diabetes: epidemiology and prevention. Diabetes Care. 1989;12: 24-31
Birke JA, Sims DS. Plantar sensory thresholds in the ulcerative foot. Leprosy Reviews. 1986;57:261-7.
Boulton AJM, Armstrong DG, Albert SF, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Associa- tion of Clinical Endocrinologists. Diabe- tes Care 2008; 31: 1679–1685.
Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nature reviews Disease primers. 2019; 5(1):41. Epub 2019/06/15. https://doi.org/10.1038/ s41572-019-0092-1 PMID: 31197153.
Feldman EL, Nave KA, Jensen TS, Bennett DL. New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain. Neuron. 2017; 93(6):1296–313. Epub 2017/03/24. https://doi.org/10.1016/j. neuron.2017.02.005 PMID: 28334605; PubMed Central PMCID: PMC5400015.
Gelberman RH, Szabo RM, Williamson RV, Dimick MP. Sensibility testing in peripheral nerve compression syndromes. J Bone Joint Surg [Am]. 1983;65:632-8.
Gylfadottir SS, Itani M, Kristensen AG, Karlsson P, Krøigård T, Bennett DL, et al. (2022) The characteristics of pain and dysesthesia in patients with diabetic polyneuropathy. PLoS ONE 17(2): e0263831. https://doi.org/10.1371/journal. pone.0263831
International Consensus on the Diabetic Foot. International Working Group on the Diabetic Foot, 2007.
Kochman A, Carnegie D, Burke T. Symptomatic Reversal of Peripheral Neuropathy in Patients with Diabetes. Journal of the American Podiatric Medical Association 2002; 92:3
KUMAR S, FERNANDO DJ, VERES A, ET AL: Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk for foot ulceration. Diabetes Res Clin Pract 13:63, 1991.
Mayfield JA, Sugarman JR. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in per- sons with diabetes. J Fam Pract 2000; 49(Suppl. 11): S17–S29.
OLMOS PR, CATALAND S, O’DORISIO TM, ET AL: The Semmes-Weinstein monofilament as a potential predictor of foot ulceration in patients with noninsulin-dependent diabetes. Am J Med Sci 309: 76, 1995.
Semmes J, Weinstein S, Ghent L, Teuber HL. Normative study. In: Semmes J; ed. Somatosensory Changes After Penetrating Brain Injuries in Man. Cambridge, MA: Harvard University Press; 1960:4-11.
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293: 217–228. Copyright © 2013 John Wiley & Sons, Ltd.
SOSENKO JM, SPARLING YH, HU D, ET AL: Use of the Semmes-Weinstein monofilament in the strong heart study: risk factors for clinical neuropathy. Diabetes Care 22: 1715, 1999.
Szabo RM, Gelberman RH, Dimick MP. Sensibility testing in patients with carpal tunnel syndrome. J Bone Joint Surg [Am]. 1984;66:60-4.
TREMONT-LUKATS IW, MEGEFF C, BACKONJA MM: Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs 60: 1029, 2000.
Weise MD, Garfin SR, Gelberman RH, Katz MM, Thorne RP. Lower extremity sensibility testing in patients with herniated intervertebral lumbar discs. J Bone Joint Surg [Am]. 1985;67:1219-24.
Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nature medicine. 2006; 12(1):62–6. Epub 2006/01/07. https://doi.org/10.1038/ nm0106-62 PMID: 16397571.
Каменов З. Диабетна невропатия, 2006
